Produkty 87304-65-2

CAS 87304-65-2 występuje w naszej ofercie pod nazwami: (3alpha,5beta,17alpha)-13-Ethyl-18,19-dinorpregnane-3,17-diol, (3α,5β,17α)-13-Ethyl-18,19-dinorpregnane-3,17-diol. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 50mg, 5mg, 25mg, 100mg.

(3alpha,5beta,17alpha)-13-Ethyl-18,19-dinorpregnane-3,17-diol
TRC
  • opakowanie: 50mg, 5mg
  • Warianty: 2
Zobacz produkt
(3α,5β,17α)-13-Ethyl-18,19-dinorpregnane-3,17-diol
Biosynth
  • opakowanie: 50mg, 25mg, 100mg
  • Warianty: 3
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3R,5R,8R,9R,10S,13S,14S,17S)-13,17-diethyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol (CAS 87304-65-2) to związek chemiczny o wzorze sumarycznym C21H36O2 i masie molowej 320.5 g/mol. Nazwa systematyczna IUPAC: (3R,5R,8R,9R,10S,13S,14S,17S)-13,17-diethyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol. InChIKey: KQIPRUISTDIUTD-UJCQGIJZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H36O2
Masa molowa320.5 g/mol
Nazwa IUPAC(3R,5R,8R,9R,10S,13S,14S,17S)-13,17-diethyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol
InChIKeyKQIPRUISTDIUTD-UJCQGIJZSA-N
SMILESCC[C@]12CC[C@@H]3[C@H]4CC[C@H](C[C@H]4CC[C@H]3[C@@H]1CC[C@]2(CC)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (3alpha,5beta,17alpha)-13-Ethyl-18,19-dinorpregnane-3,17-diol, 13beta,17alpha-Diethyl-3alpha,17beta-dihydroxy-5beta-gonane, 13beta,17alpha-Diethyl-5beta-gonane-3alpha,17beta-diol, 18,19-Dinorpregnane-3,17-diol, 13-ethyl-, (3alpha,5beta,17alpha)-, 13ss,17a-Diethyl-3a,17ss-dihydroxy-5ss-gonane
Powiązane formy tego związku
(3R,5S,8R,9R,10S,13S,14S,17S)-13,17-diethyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C21H36O2
Izomery (ten sam wzór sumaryczny)
(9Z,12Z,15Z)-henicosa-9,12,15-trienoic acid C21H36O2
methyl (5Z,8Z,11Z)-icosa-5,8,11-trienoate C21H36O2
(3S,5R,8R,9S,10S,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol C21H36O2
(3R,5R,8R,9S,10S,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol C21H36O2
(12E,15E,18E)-henicosa-12,15,18-trienoic acid C21H36O2
(3R,5S,8R,9S,10S,13S,14S,17S)-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol C21H36O2
(2R,3S,5S,8R,9S,10S,13S,14S,17S)-2,10,13,17-tetramethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol C21H36O2
(3S,8R,9S,10S,13S,14S,17S)-3,10,13,17-tetramethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C21H36O2
(3R,5R,7R,8R,9S,10S,13S,14S,17S)-7,10,13,17-tetramethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol C21H36O2
(3R,5R,7S,8R,9S,10S,13S,14S,17S)-7,10,13,17-tetramethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol C21H36O2
5-pentadecylbenzene-1,3-diol C21H36O2